Needing support, information and friendship? Sign up below for the
HealthyPlace.com "Lexapro Users" newsletter list.
About LEXAPRO®
What Is LEXAPRO?
LEXAPRO (escitalopram oxalate) is a medicine approved by the U.S. Food
and Drug Administration (FDA) for the
treatment of major depressive disorder
(MDD) and as maintenance therapy to prevent people with depression from
experiencing relapse. It is an effective and well-tolerated selective
serotonin reuptake inhibitor (SSRI). SSRI medications work by increasing the
activity of serotonin, a brain chemical involved in depression.
Clinical trials suggest that many patients' depressive symptoms may begin
to improve within a week or two after taking LEXAPRO. Full antidepressant
effects may take 4 to 6 weeks.
LEXAPRO is also approved by the FDA for
treating generalized anxiety
disorder (GAD). Many SSRIs are prescribed for this purpose and your doctor
may prescribe LEXAPRO to treat anxiety problems.
Important Safety Information
Lexapro®
IMPORTANT SAFETY INFORMATION – Depression and certain other
psychiatric disorders are themselves associated with increases in the
risk of suicide. Antidepressants increased the risk of suicidality
(suicidal thinking and behavior) in children, adolescents, and young
adults in short-term studies of major depressive disorder (MDD) and
other psychiatric disorders. Anyone considering the use of
antidepressants in children, adolescents or young adults must balance
the risk to clinical need. Patients of all ages started on
antidepressant therapy should be closely monitored and observed for
clinical worsening, suicidality or unusual changes in behavior,
especially at the beginning of therapy or at the time of dose changes.
This risk may persist until significant remission occurs. Families and
caregivers should be advised of the need for close observation and
communication with the prescriber. Lexapro is not approved for use in
pediatric patients.
Lexapro is contraindicated in patients taking monoamine oxidase
inhibitors (MAOIs), pimozide (see DRUG
INTERACTIONS – Pimozide and Celexa), or in patients with
hypersensitivity to escitalopram oxalate. As with other SSRIs, caution is
indicated in the coadministration of tricyclic antidepressants (TCAs) with
Lexapro. SSRIs and SNRIs (including Lexapro) and other psychotropic drugs
that interfere with serotonin reuptake may increase the risk of bleeding
events. Concomitant use of aspirin, NSAIDs, warfarin and other
anticoagulants may add to the risk. Patients should be cautioned about these
risks. SSRIs and SNRIs have been associated with clinically significant
hyponatremia. Elderly patients or patients taking antidiuretics or who are
otherwise volume-depleted appear to be at a greater risk. Discontinuation of
Lexapro should be considered in patients with symptomatic hyponatremia and
appropriate medical intervention should be instituted. The most common
adverse events with Lexapro versus placebo (approximately 5% or greater and
approximately 2x placebo) were nausea, insomnia, ejaculation disorder,
somnolence, increased sweating, fatigue, decreased libido, and anorgasmia.
How is LEXAPRO related to Celexa®?
LEXAPRO (escitalopram) is the active component of the antidepressant
Celexa (citalopram). It was created using a relatively new approach that
removed inactive ingredients in Celexa – yielding a safer and more potent
form of the medication.
But because LEXAPRO contains a more purified form of the active
ingredient in Celexa, it can be given at a much lower dose, providing
powerful therapy in a well-tolerated SSRI. A clinical trial of LEXAPRO in
people with moderate to severe depression found that a dose of 10 mg per day
of LEXAPRO was as effective as a dose of 40 mg a day of Celexa.
Celexa is a registered trademark of Forest
Laboratories, Inc.
*Page content provided by Forest Laboratories
top ~
next ~
send page to
friend
Lexapro Center Links
home ~ site map ~
about
Lexapro ~ Lexapro pharmacology faqs ~ side
effects ~
articles ~ depression test
disclaimer
~ email us
Depression Center ~ Anxiety-Panic Center
|